| Improved isolation strategies to increase the yield and purity of human urinary exosomes for biomarker discovery AH Gheinani, M Vögeli, U Baumgartner, E Vassella, A Draeger, ... Scientific reports 8 (1), 3945, 2018 | 182 | 2018 |
| miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas S Haemmig, U Baumgartner, A Glück, S Zbinden, MP Tschan, A Kappeler, ... Cell death & disease 5 (6), e1279-e1279, 2014 | 89 | 2014 |
| miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer U Baumgartner, F Berger, A Hashemi Gheinani, SS Burgener, ... Molecular cancer 17, 1-15, 2018 | 86 | 2018 |
| miR-29b mediates NF-κB signaling in KRAS-induced non–small cell lung cancers S Langsch, U Baumgartner, S Haemmig, C Schlup, SC Schäfer, ... Cancer research 76 (14), 4160-4169, 2016 | 60 | 2016 |
| Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer J Tschui, E Vassella, N Bandi, U Baumgartner, V Genitsch, D Rotzer, ... Virchows Archiv 466, 703-710, 2015 | 53 | 2015 |
| MicroRNA dysregulation in the tumor microenvironment influences the phenotype of pancreatic cancer E Karamitopoulou, S Haemmig, U Baumgartner, C Schlup, M Wartenberg, ... Modern Pathology 30 (8), 1116-1125, 2017 | 42 | 2017 |
| A drug screening pipeline using 2D and 3D patient-derived in vitro models for pre-clinical analysis of therapy response in glioblastoma S Lenin, E Ponthier, KG Scheer, ECF Yeo, MN Tea, LM Ebert, ... International Journal of Molecular Sciences 22 (9), 4322, 2021 | 29 | 2021 |
| A novel patient stratification strategy to enhance the therapeutic efficacy of dasatinib in glioblastoma OT Alhalabi, MNC Fletcher, T Hielscher, T Kessler, T Lokumcu, ... Neuro-Oncology 24 (1), 39-51, 2022 | 25 | 2022 |
| The dystroglycan receptor maintains glioma stem cells in the vascular niche BW Day, JD Lathia, ZC Bruce, RCJ D’Souza, U Baumgartner, KS Ensbey, ... Acta neuropathologica 138, 1033-1052, 2019 | 24 | 2019 |
| Tumor necrosis factor-α initiates miRNA-mRNA signaling cascades in obstruction-induced bladder dysfunction I Koeck, AH Gheinani, U Baumgartner, E Vassella, R Bruggmann, ... The American journal of pathology 188 (8), 1847-1864, 2018 | 17 | 2018 |
| Q-Cell glioblastoma resource: proteomics analysis reveals unique cell-states are maintained in 3D culture RCJ D’Souza, C Offenhäuser, J Straube, U Baumgartner, A Kordowski, ... Cells 9 (2), 267, 2020 | 15 | 2020 |
| Concordant miRNA and mRNA expression profiles in humans and mice with bladder outlet obstruction AH Gheinani, I Köck, E Vasquez, U Baumgartner, A Bigger-Allen, BS Sack, ... American journal of clinical and experimental urology 6 (6), 219, 2018 | 11 | 2018 |
| Integrated longitudinal analysis of adult grade 4 diffuse gliomas with long-term relapse interval revealed upregulation of TGF-β signaling in recurrent tumors E Kashani, D Schnidrig, AH Gheinani, MS Ninck, P Zens, T Maragkou, ... Neuro-oncology 25 (4), 662-673, 2023 | 9 | 2023 |
| miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas. Cell Death Dis. 2014; 5: e1279 S Haemmig, U Baumgartner, A Gluck, S Zbinden, MP Tschan, A Kappeler | 4 | |
| Preventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using the OLIG2 inhibitor CT-179 Y Li, C Lim, T Dismuke, DS Malawsky, S Oasa, ZC Bruce, C Offenhäuser, ... Research Square, 2023 | 1 | 2023 |
| Targeting OLIG2 increases therapeutic responses in SHH medulloblastoma mouse models and patient-derived medulloblastoma organoids Y Li, T Dismuke, C Lim, ZC Bruce, C Offenhäuser, U Baumgartner, ... bioRxiv, 2022.02. 14.480293, 2022 | 1 | 2022 |
| miR-125b confers NF-kappa B activity and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas S Haemmig, U Baumgartner, S Zbinden, A Glueck, M Tschan, A Kappeler, ... EUROPEAN JOURNAL OF CANCER 50, S125-S125, 2014 | 1 | 2014 |
| P17. 11. A DEVELOPMENT AND CHARACTERISATION OF THE QCELL-R RECURRENT GLIOBLASTOMA PRIMARY CELL LINE RESOURCE: MODELS TO DRIVE BREAKTHROUGH DISCOVERIES IN BRAIN CANCER KA Bradbrook, U Baumgartner, FM Smith, R Johnston, L Harris, S Hoyte, ... Neuro-Oncology 25 (Supplement_2), ii119-ii119, 2023 | | 2023 |
| Systematic microRNA screening identifies miR‐19b as regulator of temozolomide response through targeting PP2A serine‐threonine phosphatase in glioblastoma E Kashani, K Hlavackova, S Haemmig, MC Sadowski, J Phour, ... bioRxiv, 2023.01. 16.524069, 2023 | | 2023 |
| Integrated longitudinal analysis of glioblastomas with long-term relapse interval revealed upregulation of the Tumor Growth Factor β signaling pathway in the recurrent tumor E Kashani, D Schnidrig, AH Gheinani, MS Ninck, P Zens, T Maragkou, ... Institute of Pathology, University of Bern, 2022 | | 2022 |
Erik VassellaHead molecular pathology, University of BernBestätigte E-Mail-Adresse bei pathology.unibe.ch
